RGDX Financial Facts
Research and development: 268.2KTotal comprehensive loss: -4.05M
See Full Income Statement
Total liabilities: 15.72M
Accounts payable: 1.71M
See Full Balance Sheet
Response Genetics (RGDX) Earnings
|
Expand Research on RGDX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -42.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -22.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/14/15  |
 |
Q115 | -$0.10 | N/A | N/A | $3.8M | $3.9M | N/A |  | | Details |
| 3/31/15 | Q414 | -$0.09 | N/A | N/A | $4.1M | $4.8M | N/A | | | Details | |
| 8/14/14 | Q214 | -$0.08 | N/A | N/A | $4.3M | $3.9M | N/A | | | Details | |
| 5/8/14 | Q114 | -$0.03 | -$0.06 | +$0.03 | $3.9M | $5.5M | N/A | | | Details | |
| 3/20/14 | Q413 | -$0.09 | -$0.07 | -$0.02 | $4.8M | $5.3M | N/A | | | Details | |
| 11/7/13 | Q313 | -$0.08 | -$0.07 | -$0.01 | $4.1M | $5.4M | N/A | | | Details | |
| 8/8/13 | Q213 | -$0.11 | -$0.04 | -$0.07 | $5.3M | $5.4M | N/A | | | Details | |
| 5/14/13 | Q113 | -$0.03 | -$0.04 | +$0.01 | $5.6M | $4.92M | N/A | | | Details |
